Categories AlphaGraphs, Earnings, Health Care
Thermo Fisher Scientific (TMO) Earnings: 2Q20 Key Numbers
Thermo Fisher Scientific Inc. (NYSE: TMO) today announced its second quarter financial results for the period ended June 27, 2020.
Net income for the second quarter was $1.15 billion, or $2.90 per share, compared to net income of $1.12 billion, or $2.77 per share in the second quarter of 2019
Revenues up 10% to $6.97 billion.
Our teams worked with relentless intensity to establish Thermo Fisher as a global leader in COVID-19 testing and leverage our pharma services leadership to support the development and production of therapeutics and vaccines. At the same time, we continued to execute our growth strategy, developing new products and capabilities across our businesses that will position us well for years to come.
– Marc N. Casper, CEO
Most Popular
Netflix (NFLX): Four reasons why this leader will not be easy to overthrow
Netflix (NASDAQ: NFLX) has for long been the undisputed king of the streaming space. The streaming industry is seeing massive growth with several new players entering the field. It also
Fastenal (FAST) sees strong post-COVID prospects: Is the stock a buy?
The demand for services that involve minimal human interaction is on the rise as people continue to practice social distancing. Fastenal Co. (NASDAQ: FAST), a market-leading supplier of vending machines,
HEXO Corp. (HEXO) Earnings: 3Q21 Key Numbers
HEXO Corp. (NYSE: HEXO) reported its third-quarter 2021 earnings results today. Net revenue rose 2% year-over-year to CAD22.6 million. Net loss narrowed to CAD20.7 million from a loss of CAD19.5
